Nasopharyngeal angiofibroma: a twenty year study

Area of Science:

• Oncology
• Radiology
• Otorhinolaryngology

Background:

• Juvenile nasopharyngeal angiofibroma (JNA) is a rare, benign tumor.
• Treatment of JNA traditionally involves surgery, which can be associated with significant morbidity.
• Radiotherapy offers a less invasive alternative for managing JNA.

Purpose of the Study:

• To evaluate the efficacy and safety of radiotherapy for treating juvenile nasopharyngeal angiofibroma.
• To compare radiotherapy outcomes with surgical interventions.
• To assess long-term complications and recurrence rates following radiotherapy.

Main Methods:

• Retrospective analysis of 45 cases of JNA treated with a single moderate dose of radiotherapy.
• Detailed follow-up including clinical assessment and imaging.
• Emphasis on sophisticated radiotherapy techniques to minimize irradiated tissue volume.

Main Results:

• An approximate 80% initial control rate was achieved with radiotherapy.
• The remaining patients achieved control with further irradiation.
• Minimal immediate side effects and no observed late complications or secondary tumors in 2-20 years of follow-up.

Conclusions:

• Radiotherapy is a highly effective and safe treatment for juvenile nasopharyngeal angiofibroma.
• It demonstrates superiority over surgery due to lower morbidity and excellent long-term outcomes.
• A policy of observation post-radiotherapy is recommended due to ongoing tumor regression.